Pharmacodynamics and vascular effects
Cinnarizine is classified as a calcium channel blocker (CCB). Its key pharmacological feature lies in its selective action on cerebral blood flow, specifically on the cerebral arterioles.
The mechanism of vascular action consists of several components:
- The drug effectively reduces the sensitivity and reactivity of the vascular smooth muscle wall to the action of endogenous vasoconstrictors. Such vasoconstrictive substances include catecholamines, angiotensin, bradykinin, and vasopressin.
- In addition to its central action, cinnarizine exerts a moderate vasodilating effect on peripheral blood vessels, which broadens the scope of its clinical application.
Impact on blood rheology and microcirculation
A crucial aspect of cinnarizine's pharmacodynamics is its ability to alter blood fluidity (the rheological effect). This occurs through two main mechanisms:
- Increased erythrocyte elasticity. The drug increases the deformability (plasticity) of red blood cells. This allows them to pass more easily through narrowed capillaries.
- Reduced viscosity. Cinnarizine decreases pathologically elevated blood viscosity.
The final result of this dual action (vascular and rheological) is a pronounced improvement in microcirculation. This effect is crucial for restoring blood supply in ischemic zones of the brain where vessel lumens are narrowed and blood flow is hindered.
Clinical application in neurology
Indications for prescribing cinnarizine directly stem from its ability to improve cerebral and peripheral blood flow, as well as the presence of additional pharmacological properties. In neurological and vascular surgery, the drug is used to treat the following conditions:
- Therapy for residual effects following an acute cerebrovascular accident (stroke).
- Treatment of consequences of traumatic brain injury (TBI).
- Prevention and complex treatment of various peripheral circulation disorders.
Additional properties and treatment of kinetoses
In addition to its action on calcium channels, cinnarizine possesses moderate antihistamine activity. This property accounts for its ability to reduce the excitability of the vestibular apparatus.
Due to the suppression of vestibular reactions, the drug has become a specific agent for combating motion sickness (kinetoses). It is widely used for the prevention of seasickness and airsickness.
Dosing regimen for motion sickness:
- The recommended dose is 25 mg.
- The drug should be taken 30 minutes before the planned trip or flight.
- If necessary (for a long journey), the dose can be repeated after 6 hours.
Safety profile and adverse effects
Despite its selectivity of action, cinnarizine therapy may be accompanied by a number of adverse reactions. Characteristic side effects include:
- Drowsiness (this sedative effect is directly related to the antihistamine component of the drug).
- Dry mouth.
- Various dyspeptic disorders (gastrointestinal disturbances).
Precautions: If the patient is prescribed a long-term course of therapy, the physician must ensure strict monitoring of the body's condition. Mandatory monitoring includes liver function, kidney function, and the peripheral blood picture.
Briefly: answers to topical questions
To which chemical group and generation of calcium channel blockers does cinnarizine belong?
Cinnarizine belongs to the pharmacological group of calcium channel blockers (calcium antagonists). The drug is distinguished by its pronounced tropism for cerebral arterioles and selective influence on cerebral blood flow. Unlike some other members of the group, it reduces the sensitivity of vascular smooth muscle to endogenous vasoconstrictors (such as catecholamines, angiotensin, bradykinin, and vasopressin). Data on cinnarizine's belonging to a specific chemical group or a particular generation of calcium channel blockers are not presented in sources.
In which neurological and vascular pathologies is the use of cinnarizine indicated?
The use of cinnarizine is indicated for:
- residual effects after strokes;
- consequences of traumatic brain injuries;
- peripheral circulation disorders — for prevention and treatment;
- early-stage cerebral atherosclerosis as a vasodilator;
- meningovascular syphilis as a vasoprotector;
- motion sickness (kinetoses) for the prevention of seasickness and airsickness;
- gastroesophageal reflux disease — as part of neurotropic therapy as a vasoactive drug.
What side effects are characteristic of cinnarizine?
Cinnarizine is characterized by a number of adverse reactions that require monitoring during long-term therapy. The main side effects include:
- Drowsiness — a sedative effect directly related to the presence of an antihistamine component in the drug.
- Dry mouth — a frequent adverse event upon administration.
- Dyspeptic disorders — gastrointestinal disturbances.
In addition, in patients with Parkinson's disease, the use of cinnarizine carries a high risk of worsening their condition. To minimize risks during a long course of treatment, regular monitoring of liver function, kidneys, and peripheral blood count is necessary.
To remember the effects of cinnarizine, use the rule of three "C"s: Cerebral vessels (dilates arterioles), Circulation speed (improves rheology and erythrocyte deformability), Calm vestibular apparatus (helps with motion sickness).
Class and exam questions
What pharmacological group does cinnarizine belong to?
The drug belongs to the calcium channel blocker (CCB) class. Its distinguishing feature is its selective effect on cerebral blood flow and cerebral arterioles.
How does the drug improve blood flow properties?
Cinnarizine reduces elevated total blood viscosity while simultaneously increasing erythrocyte elasticity (deformability). This allows blood cells to penetrate more easily into the narrowed capillaries of ischemic zones.
How to properly take the drug for motion sickness prevention?
For kinetoses (seasickness or airsickness), it is recommended to take 25 mg of the drug 30 minutes before the start of the trip. If the journey is long, the dose can be repeated after 6 hours.
Which parameters require monitoring during long-term treatment?
When prescribing a long course of therapy, the physician must regularly monitor liver and kidney function, as well as check the patient's peripheral blood count.
What else to study on this topic
- The mechanism of action of endogenous vasoconstrictors (catecholamines, angiotensin, bradykinin, vasopressin) on vascular smooth muscle.
- The role of calcium channels in regulating the tone of cerebral arterioles.
- The pathophysiology of cerebral ischemia and the significance of blood rheological properties for microcirculation.
- The connection between the antihistamine activity of drugs and the development of sedative effects and dry mouth.
- The mechanisms of development of kinetoses (motion sickness) and the role of the vestibular apparatus in this process.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Cinnarizine" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs used for cerebral circulatory disorders"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.